Dr. Jennifer Patel -- Pharmaceutical Payment Report
This page provides a comprehensive transparency report for Dr. Jennifer Patel, a Dermatology physician based in City, SC. All payment data is sourced from the CMS Open Payments (Sunshine Act) database. Dr. Jennifer Patel has received $25,928.94 in total pharmaceutical industry payments across 1 transactions from 1 pharmaceutical companies.
Physician Profile
The following profile information is sourced from the National Provider Identifier (NPI) registry and CMS Open Payments records.
- Full Name: Dr. Jennifer Patel
- Medical Specialty: Dermatology
- Practice Location: City, SC, South Carolina
- NPI Number: 1683866537
- Transparency Score: 50/100
- Payment Records Span: 2024-07-27 to 2024-07-27
Payment Summary
Dr. Jennifer Patel has received a total of $25,928.94 in pharmaceutical industry payments across 1 recorded transactions in the CMS Open Payments database. The average payment amount is $25,928.94 per transaction.
- Total Payments Received: $25,928.94
- Number of Transactions: 1
- Average Payment: $25,928.94
- Transparency Score: 50/100 -- This score reflects the overall payment profile relative to peers in Dermatology. A higher score indicates fewer or more routine payments.
- Number of Pharma Relationships: 1 pharmaceutical companies
- Drugs/Devices Referenced: 1 distinct products
Payment Breakdown by Category
The following table shows how Dr. Jennifer Patel's pharmaceutical payments break down by payment category. Understanding the mix of payment types provides important context about the nature of the doctor-pharma relationship.
| Payment Category | Amount | Description |
|---|---|---|
| Speaking & Education | $25,928.94 | Promotional speaking, CME events, and educational presentations |
The largest payment category for Dr. Jennifer Patel is Speaking & Education, accounting for 100% ($25,928.94) of total pharmaceutical payments received. This suggests active involvement in pharmaceutical company advisory and educational programs.
Pharmaceutical Company Relationships
The following pharmaceutical and medical device companies have made payments to Dr. Jennifer Patel. Click on any company name to view their full physician payment profile and spending patterns.
| Company | Total Paid | Transactions |
|---|---|---|
| AbbVie Inc | $25,928.94 | 1 |
Dr. Jennifer Patel has a financial relationship with AbbVie Inc, receiving $25,928.94 in total. Having a single pharmaceutical company relationship means all payments come from one source, which may indicate a focused consulting or research relationship.
Drugs and Medical Devices Referenced in Payments
The following drugs and medical devices have been referenced in pharmaceutical payments to Dr. Jennifer Patel. These references indicate that the payment was related to the marketing, consulting, or clinical use of these products.
- Trikafta -- Referenced in payment records from pharmaceutical companies to Dr. Jennifer Patel
The presence of a drug or device in a payment record means the pharmaceutical company associated the payment with that product. This is common for consulting fees related to a specific medication, speaking engagements about a product, or research involving a particular drug or device.
AI Transparency Analysis
The following analysis was generated by artificial intelligence based on Dr. Jennifer Patel's payment history, specialty peer comparisons, and payment pattern analysis. This analysis is not medical or legal advice.
Dr. Jennifer Patel, a dermatologist in City, SC, has received a total of $25,928.94 in pharmaceutical payments, with a single payment recorded. This payment was from AbbVie Inc. on July 27, 2024, for speaking engagement. Comparing this to the broader field of dermatology, Dr. Patel's total payment volume is significantly lower than the average. Dermatologists, particularly those involved in research or speaking on newer treatments, can receive substantial payments. The average for dermatologists can range from several thousand to tens of thousands of dollars annually, with some specialists exceeding six figures. Dr. Patel's single payment, while notable, places her well below the typical range for active engagement with pharmaceutical companies. The sole pharmaceutical relationship identified is with AbbVie Inc., amounting to the entire $25,928.94. This suggests a focused relationship, likely related to a specific product or initiative where Dr. Patel's expertise as a speaker is valued. AbbVie is a major pharmaceutical company with a significant presence in dermatology, particularly in areas like psoriasis and autoimmune conditions. A single, substantial payment for speaking indicates a potential endorsement or educational role rather than a broad, ongoing consulting or research partnership. The payment breakdown is entirely attributed to a speaking engagement. There are no recorded payments for consulting, meals, travel, research, or ownership interests. This singular focus on speaking fees is a key characteristic of Dr. Patel's payment profile. This pattern, characterized by a single, recent payment for speaking, does not inherently suggest routine professional activity that warrants closer scrutiny in the context of widespread pharmaceutical influence. Instead, it points to a specific, discrete engagement. While any payment from industry can raise questions, the isolated nature and specific purpose (speaking) of this transaction make it less indicative of a pervasive influence compared to doctors receiving numerous, varied payments over time. For patients, understanding these payments is crucial for maintaining trust and informed decision-making. Pharmaceutical payments, even for speaking, can create potential conflicts of interest, as doctors may be incentivized to favor drugs from companies they have relationships with. However, it's important to note that many physicians engage in these relationships to stay abreast of the latest research and treatments, and to educate their peers. The key is transparency and balance. Dr. Patel's profile, with its single speaking engagement, suggests a specific professional interaction rather than a deep, multifaceted financial tie. Patients should feel empowered to discuss any concerns about their doctor's prescribing habits or potential conflicts of interest openly.
Patient Guidance: Questions to Ask Your Doctor
If Dr. Jennifer Patel is your physician, here is practical guidance on how to understand and discuss pharmaceutical industry relationships:
When considering your doctor's relationship with pharmaceutical companies, it's helpful to remember that these interactions can serve both beneficial and potentially concerning purposes. Payments for speaking, consulting, or research can help doctors stay informed about new treatments and contribute to medical education. However, they can also create a perceived or actual conflict of interest, potentially influencing prescribing habits. At your next appointment, consider asking your doctor: 'Are you involved in any speaking or consulting with pharmaceutical companies, particularly those whose medications I might be prescribed?' or 'How do you stay updated on the latest treatments and research?' Red flags might include a doctor who exclusively prescribes medications from a single company they have a known relationship with, or who seems overly enthusiastic about a particular drug without clear clinical justification. Conversely, a doctor who openly discusses their relationships and demonstrates a balanced approach to treatment options is generally a positive sign. It's important to evaluate your doctor's prescribing patterns in light of these payments. If you notice a consistent pattern of prescribing expensive brand-name drugs when equally effective generics are available, and your doctor has significant industry ties, it might warrant further discussion or a second opinion. However, remember that many doctors maintain ethical standards, and payments do not automatically equate to compromised care. Transparency is key to building trust.
Peer Comparison: How Dr. Jennifer Patel Compares to Other Dermatology Physicians
Dr. Patel's total pharmaceutical payments of $25,928.94 from a single speaking engagement are considerably lower than the average for dermatologists. While averages vary widely, many dermatologists receive multiple payments throughout the year for various activities, often totaling several thousand dollars annually. Some specialists involved in clinical trials or extensive consulting can receive significantly more. Dr. Patel's profile, with one payment, places her at the lower end of engagement with the pharmaceutical industry.
Recent Payment Records
The following table shows the most recent pharmaceutical industry payments recorded for Dr. Jennifer Patel in the CMS Open Payments database. Click on any payment to view the full report.
| Company | Amount | Type | Drug/Device | Date | Conflict Level |
|---|---|---|---|---|---|
| AbbVie Inc | $25,928.94 | speaking | Trikafta | 2024-07-27 | Not Assessed |
Frequently Asked Questions About Dr. Jennifer Patel's Pharma Payments
Below are common questions patients ask about physician pharmaceutical payment data.
Is Dr. Jennifer Patel taking too much pharma money?
Dr. Patel has received a single payment of $25,928.94 for a speaking engagement. Compared to the average dermatologist, who may receive multiple payments totaling several thousand dollars annually, her total volume is relatively low. While any payment warrants consideration, the isolated nature of this transaction suggests a specific professional interaction rather than extensive financial ties that might raise significant concerns about undue influence.
What pharma companies pay Dr. Jennifer Patel?
Dr. Jennifer Patel has received payments exclusively from AbbVie Inc., totaling $25,928.94. This indicates a singular professional relationship with this pharmaceutical company.
Should I switch doctors because of pharma payments?
Switching doctors solely based on pharmaceutical payments is generally not recommended unless you have specific concerns about your care. Dr. Patel's profile shows a single payment for speaking, which is a limited engagement. If you have doubts, discuss them openly with your doctor. If you feel your concerns are not addressed or if you observe a consistent pattern of prescribing that seems questionable, then seeking a second opinion or considering a new physician might be appropriate.
What kinds of payments does this doctor receive?
Dr. Patel has received one type of payment: $25,928.94 for a speaking engagement. There are no recorded payments for consulting, meals, travel, research, or ownership interests.
How do these payments compare to other Dermatology?
Dr. Patel's total payment of $25,928.94 from a single speaking event is low compared to the average dermatologist. Many dermatologists receive multiple payments throughout the year for various activities, often accumulating to several thousand dollars annually. Her profile indicates a minimal level of financial interaction with pharmaceutical companies relative to her peers.
Do pharma payments affect prescribing quality?
Research suggests that even small payments can influence physician prescribing habits, potentially leading to increased use of brand-name drugs. However, the extent of this influence varies greatly. Many physicians maintain ethical practices and use industry relationships to stay informed. Dr. Patel's single speaking payment is less likely to indicate a pervasive influence compared to doctors with numerous, ongoing financial ties.
How can I verify this payment data?
You can verify this payment data directly through the Centers for Medicare & Medicaid Services (CMS) Open Payments database. Visit the official CMS Open Payments website, search for 'Jennifer Patel' and her NPI (1683866537), and review the detailed records of payments made to her by pharmaceutical and medical device companies.
Understanding This Doctor Payment Report
This transparency report for Dr. Jennifer Patel is based on data from the CMS Open Payments database, which is maintained by the Centers for Medicare and Medicaid Services under the Physician Payments Sunshine Act. Here are important things to understand:
- Payment does not imply wrongdoing. Many pharmaceutical payments represent legitimate professional activities such as consulting on drug development, speaking at medical education events, and conducting clinical research.
- Context matters. A large payment for conducting a clinical trial has very different implications than a large payment for promotional speaking. The payment breakdown by category above provides this context.
- Peer comparison is important. Whether a payment amount is unusual depends heavily on the physician's specialty, geographic location, and career stage. Dermatology physicians may have very different payment norms than physicians in other fields.
- Data may be incomplete. The CMS Open Payments database captures payments from pharmaceutical and medical device manufacturers. It does not include payments from other sources, such as hospitals, insurance companies, or government agencies.
- Reporting thresholds apply. Small payments below certain thresholds may not be individually reported. The totals reflect payments above reporting minimums set by CMS regulations.
About the Physician Payments Sunshine Act
The Physician Payments Sunshine Act, enacted as Section 6002 of the Affordable Care Act in 2010, requires pharmaceutical and medical device companies to report payments and other transfers of value to physicians and teaching hospitals to CMS. This law was designed to increase transparency in the financial relationships between the healthcare industry and medical providers.
Under this law, Dr. Jennifer Patel's pharmaceutical payments are publicly disclosed. The types of reportable transactions include consulting fees, compensated speaking or educational activities, honoraria, gifts, entertainment, food and beverages, travel and lodging, education or conference attendance, research grants, charitable contributions, royalties or licenses, current or prospective ownership interests, and direct compensation for services other than consulting.
The Open Payments data for Dr. Jennifer Patel and all other physicians can be accessed at the official CMS Open Payments website.
Related Resources
- Dermatology Specialty Payment Data -- See payment patterns for all dermatology physicians
- South Carolina Physician Payments -- Browse pharmaceutical payments to physicians in South Carolina
- Dermatology Physicians in South Carolina -- Compare Dr. Jennifer Patel to peers in the same state and specialty
- AbbVie Inc Payment Profile -- View all payments made by Dr. Jennifer Patel's largest pharmaceutical partner
- Search for Another Doctor or Company -- Look up any physician or pharmaceutical company in our database
- Official CMS Open Payments Database -- Verify payment data directly with the federal government
- NPI Registry -- Look up Dr. Jennifer Patel's NPI (1683866537) in the official provider registry
Data from CMS Open Payments (Sunshine Act). Payment does not imply wrongdoing. AI analysis is not medical or legal advice. Consult your healthcare provider about any concerns.